this order form below comes into view when you se
Post# of 9122
OTC Disclosure & News Service® last I knew was $4200/yr-its $10k/yr for otcqb companies as of 2014/2015 [depending on a companies fiscal year, which ,besides a new otcqb requirement of a one cent min bid price at the same time in 2014/2015-resulted in many otcqb companies [all of which -otcqb-are required to be SEC reporting] down-listing to the pink current designation
bold emphasis in the form is mine-i dont know whether the cost of the otc news and disclosure service [as they call it] has gone up to 5500/yr [ 7k on a semiannual payment basis-otc probably fears many such co's wont pay their 2nd semiannual payment] for all current pink stocks -or just those part of this initial application to become pink current
you can ignore the change of control sections-they dont pertain to NNLX as far as we know
it can be assumed skull and bones co's wont be quoted anymore either [maybe they arent quoted now- the rules are a moving target] as they are treated worse than 'no info' co's and often become ce co's due to promotions [covers a wide range of things-actual or assumed by the otc] due to otc's perception of no info or limited info co's having 'promos' -thats one of the dangers of being no info or limited info - easily becoming ce [skull and bones] at the drop of a hat[so to speak] with no warning by the otc
again there is no requirement for no info co's like NNLX to become SEC reporting -only to become pink current otc classification via a process i've detailed many times-which is an upgrade from NNLX's no info status- NOT an uplisting
i would not become SEC reporting [an uplisting if combined with a move to the OTCQB] if i were NNLX w NNLX's presumed current financial situation- that would require extra expense, extra filings and extra paperwork beyond the pink current designation[though many pink current stocks are SEC reporting because as i detailed earlier they down-listed from OTCQB in 2014/2015]
all levels of disclosure -especially the tightening rules- can be assumed to be an irritant to public companies -but this is the regulatory price of being a public company -thus able to raise funds via stock issuance until a company has sufficient revenue to be self supporting -as presumably was the hope re the NNLX's copyrighted petri plates
the wild west of the penny market -as the pre 2000 years are sometimes called -has been over for many years
its not a matter of liking something-its a matter of fact -at least the requirement for 'no info' and 'limited info' co's to become current reporting has a logical basis in investor disclosure/transparency-and as i've said is no surprise to those who have watched this evolving disclosure process over many years-
e.g OTCQX -which began in ca 2009= is up to 562 companies now as alternative to the big boards and is an up-listing from OTCQB or a down-listing from the big boards
OTCIQ Order Form – Services for Pink® Companies
Company Name:
U.S. Trading Symbol:
Address:
City, State, Zip:
Main Telephone:
Company Website:
State of Incorporation:
Select Services
0 Real-time Level 2 Quote Display Service No Application Fee, $3,000 Annual Fee
Sponsor Level 2 Quotes for your stock so investors can have free access to the same market data professional traders have. Broker-Dealer identifiers, bid and ask prices, and time & sales data delivered to investors on www.otcmarkets.com and on your corporate IR site – all in real-time.
0 OTC Disclosure & News Service® Distribute your Company’s news, research and financial reports to www.otcmarkets.com and other financial information portals, so that investors can analyze, value, and trade your Company’s stock. Select the Application Type:
0 New Application $1,000 Application Fee, 0 $5,500 Annual Fee or 0 $3,500 Semi-Annual Fee
0 Change in Control $1,000 Application Fee Annual Fee N/A
Subscribers are required to submit a new Order Form, Application Fee, board resolution verifying Change in Control and any other applicable documentation related to a change in Officers, Directors or Affiliates. Services may be suspended until OTC Markets has completed review of an Order Form following such Change in Control.
Change in Control or Court Appointed Custodian Disclosure: Subscribers are required to submit additional information if your Company is applying as a result of a Change in Control or has a Court Appointed Custodian. Information on this requirement can be found here.
Officers and Directors
Please provide a list of all Officers and Directors below.
If the Company has undergone a Change in Control Event, include the Former Officers and Directors immediately prior to the Change in Control and clearly indicate that they are former officers and directors. OTC Markets may contact the former management to confirm their resignation(s).
Position Full Name Email Phone
Control Persons: List all persons or entities owning 5% or more of any class of the issuer’s shares. If any are corporate shareholders or entities, you must also provide the name of the person(s) beneficially owning or controlling such corporate shareholders, or the name of an individual representing the corporation or entity. Beneficial Ownership includes the right to acquire the security within 60 days including, but not limited to, the exercise of options or warrants or through conversion. See Securities Exchange Act Rule 13d-3.
Full Name
Number of Shares Beneficially Owned % Shares Beneficially Owned Class of Shares
Transfer Agent Authorization
0 I have authorized the below named Transfer Agent to provide information directly to OTC Markets Group, upon its request, information related to the Company’s securities, including but not limited to, shares authorized, shares issued and outstanding, and share issuance history. Authorization is required to process this Order Form.
Firm Name:
Address:
Contact Name:
Email:
Phone Number:
Confirm Review of Stock Promotion Policy and Best Practices
0 An officer of the Company has reviewed OTC Markets Group Policy on Stock Promotion and the Best Practices for Issuers.
Authorized User(s)
Designate persons below (each an “Authorized User”) to receive Company Credentials, which are required to access the OTC Disclosure & News Service and www.otciq.com. In the event an Authorized User leaves the Company or otherwise is no longer an Authorized User, the Company must notify OTC Markets Group immediately to terminate access or assign a new Authorized User. Changes to Authorized Users should be made using the OTCIQ User Change Request Form via DocuSign. Authorized Users may not share Company Credentials.
Authorized User 1:
Name:
Title/Affiliation:
Email:
Business Phone:
Authorized User 2: (Optional)
Submit Application
Email the following application materials to OTC Markets Group at issuers@otcmarkets.com.
1. Completed OTCIQ Order Form
2. Current Shareholder List provided by your transfer agent
3. Background Check Authorization Form authorizing background checks on all Company Officers, Directors and Control Persons, as well as all Authorized Users indicated above and Billing Contacts.
4. If applying for services following a Change in Control as defined on Page 1, OTC Markets Group requests contact information for the Former Officers and Directors in the above table. You are also required to submit a board resolution and letter(s) of resignation(s). In addition, subscribers with a change in control or court appointed custodian are required to submit the Change in Control or Court Appointed Custodian Addendum.
Next Steps
1. Upon receipt of this Order Form, OTC Markets Group will send an invoice for the services applied for, to the Billing Contacts listed on Page 4. The invoice will contain instructions for payment by ACH/Wire, Check or Credit Card. OTC Markets Group will not review this Order Form until payment of the Application Fee is received.
2. OTC Markets Group may request additional information including a copy of Driver’s License or Passport for identity verification purposes, or any other documents related to this Order Form prior to providing Company Credentials. OTC Markets may, in its sole and absolute discretion, determine not to provide Company Credentials as requested on this Order Form.
3. Once the Order Form is ready for approval, an OTC Markets Group analyst will separately reach out via DocuSign to have the Company sign the OTCIQ Agreement.
4. We will verify your company information and provide Company Credentials and instructions to the Authorized User(s).
5. If applying for services following a Change in Control or Court Appointed Custodian, the Company will be asked to post the Change in Control or Court Appointed Custodian Addendum to your www.otcmarkets.com profile.
Access to this service does not guarantee that a company will move to the Current Information or Limited Information tier or that the Caveat Emptor designation will be removed.
OTCIQ Order Form - Payment Information
Fees
• Application Fees are non-refundable
• All Annual Fees are billed annually or semi-annually, in advance, as indicated by your selection on page 1
• The Application Fee and first Annual Fee/Semi-Annual Fee for services must be paid upon submission of this Order Form.
• No services will be entitled until funds are received.
OTC Markets Group will not review this application until payment of the Application Fee is received. You may submit payment in conjunction with your application per the below instructions.
ACH/Wire Payment Instructions
Customers that wish to send ACH payments to our account should use the following information:
JP Morgan Chase Money Transfer & Wire Department
4 New York Plaza New York, NY 10004 ABA
Routing Number: 021000021
Credit the Account of: OTC Markets Group Inc.
Account #: 764232302
Our bank’s SWIFT Code is: CHASUS33
To avoid delay in processing your payment, customers should include: (a) invoice number, if available or (b) OTCIQ Order Form, in the Memo Line/Special Instructions/Pay Detail of the wire transfer.
To ensure prompt and proper credits, we would appreciate customers sending payment detail (customer name or account number, invoice(s) paid, as applicable) to us via email at otcmarketsgroupbilling@otcmarkets.com or via fax to (212) 868-3828.
Billing Contact
All invoices and billing notices will be sent by email to the contact(s) listed below.
Primary Billing Contact Alternate Billing Contact
Name
Company Affiliation or Title
Address
City, State, Zip:
Telephone
For questions related to billing, you may contact OTC Markets Group Finance Department at 212-896-4405 or otcmarketsgroupbilling@otcmarkets.com.
Company Signature
I certify that the information contained in this OTCIQ Order Form is true and correct, and will notify OTC Markets Group promptly of any material changes. I further represent that any personal data provided herein has been collected, and is being shared with OTC Markets Group, in accordance with all applicable privacy laws (e.g. the required consent has been obtained from third parties).
Signature of Company Officer: ¬¬¬¬¬¬¬¬¬¬¬¬¬¬ __________________________________________________
Date:
Print Name:
Company Name: